There is no reason why a drug that we know costs no more than about $10 to manufacture should be costing seniors $100, $200.
Ron Wyden: “There is no reason why a drug that we know costs no more than about $10 to manufacture should be costing seniors $100…”
Editor's note · Context
Criticizing high insulin prices despite low manufacturing costs.
Share
More from Ron Wyden
As Congress debates solutions to protect our privacy and civil liberties, the MITRE report could provide important information about how these cameras and other surveillance programs are already impacting Americans’ rights.
The Department’s recent decision in August 2026 to quietly strip explicit prohibitions against political interference from its Scientific Integrity Policy is yet another attempt by the Trump administration to undermine scientific facts and…
Community health workers are the backbone of rural and underserved communities.
These unsung heroes deserve recognition for their tireless efforts to keep our communities safe and healthy, and I’m honored to be leading this effort in Congress.





